Medicinal Products

Ikatibant Fresenius 30 mg otopina za injekciju u napunjenoj štrcaljki

Name Ikatibant Fresenius 30 mg otopina za injekciju u napunjenoj štrcaljki
Marketing Authorisation Number HR-H-144595233
Active Substance ikatibant
Composition jedna napunjena štrcaljka od 3 ml sadrži ikatibantacetat koji odgovara količini od 30 mg ikatibanta jedan ml otopine sadrži 10 mg ikatibanta
Pharmaceutical Form otopina za injekciju u napunjenoj štrcaljki
Manufacturer Fresenius Kabi Austria GmbH, Graz, Austrija
Marketing Authorisation Holder Fresenius Kabi d.o.o., Radnička cesta 37a, Zagreb, Hrvatska
Marketing Authorisation Date 12.01.2022
MA Period of Validity 12.01.2027
Classification Number UP/I-530-09/20-01/146
Registration Number 381-12-01/70-22-04
Prescription Medicinal product subject to medical prescription
Type of prescription Medicinal product on medical prescription for renewable delivery
Distribution Supply through pharmacies (community)
Advertising to general public not allowed
ATC Code B06AC02
Marketing status Not marketed
SmPC download
PL download
Public Assessment Report download
Summary of risk management plan download

Packaging

Back